IRIS
MAIDA, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.022
EU - Europa 4.733
AS - Asia 4.159
SA - Sud America 2.815
AF - Africa 173
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 18.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.881
BR - Brasile 2.516
IT - Italia 1.841
SG - Singapore 1.671
CN - Cina 1.339
UA - Ucraina 940
HK - Hong Kong 461
DE - Germania 445
FR - Francia 438
SE - Svezia 268
FI - Finlandia 194
VN - Vietnam 136
GB - Regno Unito 112
AR - Argentina 109
IE - Irlanda 97
RU - Federazione Russa 77
NL - Olanda 73
TR - Turchia 73
BD - Bangladesh 59
IQ - Iraq 53
MX - Messico 52
CA - Canada 50
ZA - Sudafrica 50
EC - Ecuador 49
IN - India 43
CZ - Repubblica Ceca 41
PL - Polonia 39
PK - Pakistan 37
MA - Marocco 35
KR - Corea 34
UZ - Uzbekistan 31
CO - Colombia 29
BE - Belgio 27
ES - Italia 27
JP - Giappone 27
VE - Venezuela 26
AT - Austria 24
AZ - Azerbaigian 23
PY - Paraguay 23
ID - Indonesia 21
IR - Iran 19
KE - Kenya 19
UY - Uruguay 19
AE - Emirati Arabi Uniti 18
PE - Perù 18
TN - Tunisia 17
AU - Australia 16
CL - Cile 16
DZ - Algeria 14
EG - Egitto 14
KZ - Kazakistan 14
EU - Europa 11
JO - Giordania 11
CH - Svizzera 10
NP - Nepal 10
PA - Panama 10
LT - Lituania 9
RS - Serbia 9
BO - Bolivia 8
HU - Ungheria 8
LB - Libano 8
AL - Albania 7
IL - Israele 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
BH - Bahrain 6
GE - Georgia 6
OM - Oman 6
QA - Qatar 6
SN - Senegal 6
BG - Bulgaria 5
BY - Bielorussia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GA - Gabon 5
JM - Giamaica 5
KG - Kirghizistan 5
KW - Kuwait 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
GR - Grecia 3
SI - Slovenia 3
AM - Armenia 2
BN - Brunei Darussalam 2
CY - Cipro 2
GT - Guatemala 2
HR - Croazia 2
ML - Mali 2
NO - Norvegia 2
TL - Timor Orientale 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
Totale 18.910
Salva come PNG Salva come JPEG
Città #
Dallas 2.600
Chandler 913
Singapore 833
Jacksonville 557
Hong Kong 456
Princeton 332
Beijing 290
Nanjing 254
Dearborn 187
São Paulo 172
Rome 156
New York 138
Ashburn 133
Milan 130
Wilmington 124
Shanghai 108
Boardman 107
Nanchang 103
Sassari 101
Ann Arbor 97
Dublin 96
Rio de Janeiro 86
Shenyang 75
Los Angeles 67
Belo Horizonte 66
Ho Chi Minh City 62
Naples 62
Tianjin 60
Munich 59
Santa Clara 55
Woodbridge 50
Hebei 48
Changsha 46
Florence 44
Helsinki 44
Brasília 43
Porto Alegre 41
Andover 37
Brno 37
Jiaxing 37
Campinas 35
Jinan 34
Seoul 32
Hangzhou 30
Hanoi 30
Nuremberg 30
Tashkent 30
Curitiba 29
Goiânia 28
Guarulhos 28
Ningbo 28
Palermo 28
San Francisco 28
Brussels 27
Toronto 27
Bari 26
Ribeirão Preto 25
Tokyo 25
Zhengzhou 25
Norwalk 24
Warsaw 24
Turin 23
Bologna 22
Kunming 22
Baku 21
Salvador 21
Sorocaba 21
Baghdad 20
Fortaleza 20
Johannesburg 20
Turku 20
Dhaka 19
Montevideo 19
Brooklyn 17
Campo Grande 17
Juiz de Fora 17
Nairobi 17
São José dos Campos 17
Verona 17
Betim 16
Buenos Aires 16
Caxias do Sul 16
Chicago 16
Columbus 16
London 16
Recife 16
Santo André 16
São Bernardo do Campo 16
Ardabil 15
Atlanta 15
Joinville 15
San Mateo 15
Denver 14
Guangzhou 14
Leawood 14
Lima 14
Nova Iguaçu 14
Volta Redonda 14
Guayaquil 13
Montreal 13
Totale 10.163
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.742
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 265
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 253
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 209
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 198
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 197
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 180
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 172
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 166
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 160
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 160
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 157
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 154
Approccio molecolare nella diagnosi della tubercolosi umana 151
Antibiotic resistant H-pylori are extremely common in Sardinia. 151
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 150
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 148
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 145
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 144
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 144
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 144
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 142
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 141
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 126
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 125
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 125
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 124
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 121
Valutazione della qualità delle schede di dimissione ospedaliera 121
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 120
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 119
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 117
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 116
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 114
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 114
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 112
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 112
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 111
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 110
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 109
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 109
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 109
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 107
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 107
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 107
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 106
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 106
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 106
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 106
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 104
Joint replacement for avascular necrosis in people living with HIV 104
QuantiFERON TB Gold: a new method for latent tuberculosis infection 103
HIV related aneurisms 103
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 101
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 101
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 101
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 101
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review 100
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 100
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 100
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 100
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 99
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 99
Epidemiologia e prevenzione delle infezioni da Micobatteri su base molecolare 99
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 99
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 98
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 97
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 97
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 96
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 95
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 95
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 95
Serum homocysteine levels are increased in women with gestational diabetes mellitus 94
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 94
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 94
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 94
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 93
Database per il monitoraggio del rischio professionale negli operatori sanitari 93
Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype 93
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 93
Specific Genetic Determinants in NS5A and Core Regions Correlate with Genotype 1b HCV-Induced Hepatocellular Carcinoma: Implications for Viral Markers of Disease Progression 91
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 91
Evalutaion and comparison of molecular techniques for epidemiological typing of M. tuberculosis 91
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation 90
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 90
Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients 89
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 89
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 89
Database per il monitoraggio del rischio professionale negli operatori sanitari 89
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 88
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 88
Liver Fibrosis Stage and HCV Genotype Distribution in HIV-HCV Coinfected Patients with Persistently Normal Transaminases 87
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 86
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome 86
Triple-nucleoside regimens versus efavirenz 86
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir 86
Very late HCV relapse following triple therapy for hepatitis C. 85
New paradigms in the management of HIV and hepatitis C virus coinfection 85
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 85
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 84
Totale 13.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.084 0 0 0 0 155 82 164 16 244 230 138 55
2021/2022965 152 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.792 113 161 376 136 197 193 360 1.074 1.964 763 314 141
2025/20265.024 345 1.982 1.231 1.222 244 0 0 0 0 0 0 0
Totale 19.260